{
  "url": "https://openlegislation.uk/eu-regulation-1998-613/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-1998-613/annex.json",
  "legislation": "eur/1998/613",
  "legislation_title": "Commission Regulation (EC) No 613/98 of 18 March 1998 amending Annexes II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-1998-613",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "A.. Annex II is modified as follows:\n1.. Inorganic chemicals\nPharmacologically active substances(s)\nAnimal species\nOther provisions\n‘Potassium nitrate\nAll food producing species\nPotassium DL-aspartate\nAll food producing species\nPotassium glucuronate\nAll food producing species\nPotassium glycerophosphate\nAll food producing species’\nB.. Annex III is modified as follows:\n1.. Anti-infectious agents\n1.2. Antibiotics\n1.2.11. Florfenicol and related compounds\nPharmacologically active substance\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘Florfenicol\nSum of florfenicol and its metabolites measured as florfenicol-amine\nFish\n1 000 µg/kg\nMuscle and skin in natural proportions\nProvisional MRLs expire on 1.7.2001’\n2.. Antiparasitic agents\n2.1. Agents acting against endoparasites\n2.1.1. Benzimidazoles and pro-benzimidazoles\nPharmacologically active substance\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘Albendazole sulphoxide\nSum of albendazole, albendazole sulphoxide, albendazole sulphone and albendazole 2-amino sulphone, expressed as albendazole\nBovine, ovine, pheasant\n1 000 µg/kg\nLiver\nProvisional MRLs expire on 1.1.2000’\n500 µg/kg\nKidney\n100 µg/kg\nMuscle, fat\nBovine, ovine\n100 µg/kg\nMilk\n2.3. Agents acting against endo- and ectoparasites\n2.3.1. Avermectins\nPharmacologically active substance\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘Moxidectin\nMoxidectin\nEquidae\n50 µg/kg\nMuscle\nProvisional MRLs expire on 1.1.2000’\n500 µg/kg\nFat\n100 µg/kg\nLiver\n50 µg/kg\nkidney\n4.. Anti-inflammatory agents\n4.1. Nonsteroidal anti-inflammatory agents\n4.1.1. Arylpropionic acid derivative\nPharmacologically active substance\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘Carprofen\nCarprofen\nBovine\n1 000 µg/kg\nLiver, kidney\nProvisional MRLs expire on 1.1.2000’\n500 µg/kg\nMuscle, fat\nEquidae\n1 000 µg/kg\nLiver, kidney\n50 µg/kg\nMuscle\n100 µg/kg\nFat\nC.. Annex IV is modified as follows:\nList of pharmacologically active substances for which no maximum levels can be fixed\n‘Metronidazole.’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/1998/613/annex",
    "retrieved_at": "2026-11-01T14:58:24.627349+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}